Circulating tumour DNA as biomarker for rectal cancer: A systematic review and meta-analyses

BACKGROUND: Circulating tumour DNA (ctDNA) has been established as a promising (prognostic) biomarker with the potential to personalise treatment in cancer patients. The objective of this systematic review is to provide an overview of the current literature and the future perspectives of ctDNA in no...

Descripción completa

Detalles Bibliográficos
Autores principales: van Rees, Jan M., Wullaert, Lissa, Grüter, Alexander A. J., Derraze, Yassmina, Tanis, Pieter J., Verheul, Henk M. W., Martens, John W. M., Wilting, Saskia M., Vink, Geraldine, van Vugt, Jeroen L. A., Beije, Nick, Verhoef, Cornelis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922989/
https://www.ncbi.nlm.nih.gov/pubmed/36793616
http://dx.doi.org/10.3389/fonc.2023.1083285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922989/
https://www.ncbi.nlm.nih.gov/pubmed/36793616
http://dx.doi.org/10.3389/fonc.2023.1083285

Ejemplares similares